NCT03175094

Brief Summary

After enrollment, participants will be randomized to either receive the intervention (treatment) from trained health educators or undergo observation as usual (control group). Randomization will be stratified by HIV serostatus. A control group is appropriate because participants will still receive services offered through probation and will be offered the intervention after completion of the trial. Subjects will be paid, not for participating in the intervention, but for providing research assessments. The newly adapted intervention will be delivered over no more than a 3-month period (it will be shorter if the adaptation process is supportive). Baseline assessments will assess the pre-intervention period. The 3-month assessment will be the end-of-intervention effects and the post-intervention assessments will be at 6, 9 and 12 months. HIV prevention knowledge will be assessed based on quizzes used previously for HHRP+; though final quiz content will depend on final selected materials for the intervention. Subjects will be followed for 12 months with assessments by trained research assistants.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P25-P50 for not_applicable hiv

Timeline
Completed

Started Mar 2015

Typical duration for not_applicable hiv

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 3, 2015

Completed
2.2 years until next milestone

First Submitted

Initial submission to the registry

May 24, 2017

Completed
12 days until next milestone

First Posted

Study publicly available on registry

June 5, 2017

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 10, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 10, 2017

Completed
Last Updated

August 4, 2021

Status Verified

August 1, 2021

Enrollment Period

2.7 years

First QC Date

May 24, 2017

Last Update Submit

August 3, 2021

Conditions

Keywords

womenHIV preventioncriminal justice

Outcome Measures

Primary Outcomes (1)

  • Change in HIV knowledge from baseline

    HIV knowledge quiz with scores ranging from 0-100, a higher score indicating better knowledge

    3 months

Secondary Outcomes (2)

  • Change in Sex-related risk behaviors over time

    baseline, 6 months, 12 months

  • Change in Injection-related risk behaviors over time

    baseline, 6 months, 12 months

Study Arms (2)

Holistic Health Recovery Program for HIV+ Intervention

EXPERIMENTAL
Behavioral: Holistic Health Recovery Program for HIV+

Control

NO INTERVENTION

Interventions

Holistic Health Recovery Program for HIV+ (HHRP+) is a CDC-recommended, evidence based behavioral (psychoeducational) group intervention focused on harm reduction principles. The investigators systematically adapted HHRP+ using findings from qualitative interviews with the target population of adult women living with and at-risk for HIV who are justice-involved (on probation, parole, or recently released from prison or jail).

Holistic Health Recovery Program for HIV+ Intervention

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age ≥18 years old
  • female
  • have laboratory confirmed HIV OR are at-risk for HIV (ever injected drugs, ever engaged in commercial sex work, were incarcerated in prison or jail within the past 2 years, had condomless sex with an HIV+ partner or partner whose HIV status is unknown in the past 90 days, or had a diagnosed sexually transmitted infection in the past 90 days),
  • and are under or anticipating transfer to probation.are either a) sentenced to probation or on intensive pretrial supervision by a probation officer; b) sentenced to parole; or c) incarcerated in jail or prison in the prior 60 days.
  • Potential participants will be excluded

You may not qualify if:

  • unable or unwilling to provide informed consent,
  • have \<3 months of remaining scheduled supervision term,
  • or are threatening to staff

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yale AIDS Program

New Haven, Connecticut, 06106, United States

Location

MeSH Terms

Interventions

Seroconversion

Intervention Hierarchy (Ancestors)

Immune System Phenomena

Study Officials

  • Jaimie Meyer, M.D., M.S.

    Yale University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 24, 2017

First Posted

June 5, 2017

Study Start

March 3, 2015

Primary Completion

November 10, 2017

Study Completion

November 10, 2017

Last Updated

August 4, 2021

Record last verified: 2021-08

Data Sharing

IPD Sharing
Will not share

Locations